XLO — Xilio Therapeutics Share News
0.000.00%
Last trade - 00:00- $49.81m
- -$86.23m
- $43.77m
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla
U.S. STOCKS ON THE MOVE-Energy firms, Cencora, Stryker
Xilio rises after surprise quarterly profit
Xilio Therapeutics posts Q4 profit on higher collaboration revenue
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Xilio Therapeutics Announces Pricing Of Underwritten Offering
Brief: Xilio Therapeutics Inc Appoints Sara Bonstein As Chair Of Board
Xilio Therapeutics' Q3 collaboration revenue rises
Brief: Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
Brief: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Xilio Therapeutics Announces Upcoming Presentations At The Society For Immunotherapy Of Cancer